IN-SILICO ANALYSIS OF SOME PHYTOCHEMICALS AS POTENTIAL THERAPEUTIC INHIBITORS AGAINST BREAST CANCER
AbstractBreast cancer continues to pose a serious hazard to women worldwide. (EGFR) was one of the first key targets for these new anticancer drugs to be discovered. Triple-negative breast cancer affects almost half of all women in the World. This study focused on the phytochemicals from a medicinal plant Clitoria ternatea; these medicinal plants possess more phytochemical compounds that effectively fight against cancer cells. The five compounds were selected and a molecular docking study was performed against EGFR protein. The Pharmacokinetics and ADMET properties of these ligands help identify the best hits. Myricetin exhibits the highest binding energy among these five ligand molecules and is the best ligand to inhibit EGFR protein. Hence, this compound may act as a promising agent for treating breast cancer. However, more in-vivo and in-vitro testing is needed to establish their safety and efficacy in this area.
Article Information
27
3635-3640
904 KB
387
English
IJPSR
R. Durga and Y. Suneetha *
Department of Zoology, Sri Venkateswara University, Tirupati, Andhra Pradesh, India.
ysuneethareddy4@gmail.com
27 January 2022
03 March 2022
27 April 2022
10.13040/IJPSR.0975-8232.13(9).3635-40
01 September 2022
Download